Filing Details
- Accession Number:
- 0001209191-20-006289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 16:13:25
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-04 16:13:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-31 | 3,909 | $187.53 | 38,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-31 | 3,909 | $238.65 | 35,003 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,344 | $231.21 | 33,659 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-02-03 | 2,330 | $86.52 | 35,989 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-03 | 574 | $229.07 | 35,415 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 612 | $230.02 | 34,803 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 1,350 | $231.20 | 33,453 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 1,500 | $231.84 | 31,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 400 | $233.03 | 31,553 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-31 | 3,909 | $0.00 | 3,909 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-03 | 2,330 | $0.00 | 2,330 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,945 | 2029-02-05 | No | 4 | M | Direct | |
| 9,320 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $229.07 (range $228.44 to $229.42).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.02 (range $229.48 to $230.47).
- Open market sales reported on this line occurred at a weighted average price of $231.20 (range $230.53 to $231.52).
- Open market sales reported on this line occurred at a weighted average price of $231.84 (range $231.58 to $232.44).
- Open market sales reported on this line occurred at a weighted average price of $233.03 (range $232.95 to $233.26).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
